Inizio Evoke’s Post

We asked our Senior Client Partner, Inizio Evoke Europe, Anna Capers, what she is most looking forward to at #ESMO24 next week. Swipe below to find out ➡️.   #ESMO2024 #Oncology #CancerResearch #MedicalInnovation #HealthcareMarketing #InizioEvoke Inizio

We are advancing two novel technologies to overcome primary and secondary resistance to current #immunotherapies. https://bit.ly/47ShQvv #oncology #personalcancervaccine #merkelcell #squamouscell

As February draws to a close, we acknowledge it is #NationalCancerPreventionMonth, which aims to educate people on ways they could modify their behavior to live a healthier lifestyle. #NationalCancerPreventionMonth #Oncology #Cancerprevention #breastcancer #prostatecancer

🌟 New on the blog! Dive into our latest “In The Spotlight” series with an exclusive interview featuring Debarati Biswas, the brilliant product manager behind LARVOL PULSE. Learn about her motivations and the impact of her work in drug research. Don’t miss this inspiring read: https://bit.ly/4bWxkjH! 🤩 #InTheSpotlight #OnTheBlog #DrugResearch #Oncology #CancerResearch #PrecisionMedicine #CompetitiveIntelligence #LARVOLPULSE #LARVOL

Congratulations to Angela DeMichele, Scientific Chair of #ASCO2024, for an outstanding scientific program! Exciting to see so many new practice-changing data being presented. #Oncology #CancerResearch #ASCO #MedicalInnovation"

On World Cancer Day, we commit to reducing the care gap by addressing unmet medical needs. #worldcancerday #closethecaregap #cancercare #oncology #idrslabs #research #innovation #cancercure #accessibility #drugdevelopment

Key opinion leaders outline a case study of a patient with metastatic castration-sensitive #ProstateCancer, detailing the chosen treatment approaches and the overall outcome of the case. #pcsm #oncology https://lnkd.in/eckMriPt

Our EPICS Global Perspectives in #BreastCancer report will provide worldwide reactions to new data from #ESMO24. To get the report and observe the discussion: https://lnkd.in/eUnmaV9q Topics include approaches in triple negative; new standards in HR+, HER2–; and HER2+. #CancerCare #Oncology #ESMO2024

If I have learned little about any clinical trial concepts, terminolgies, and obviously its from her!!! Have always learned something new from her calls. Debarati Biswas This is great read👏👏 kudos 👏#LARVOL #Pulse #productupdates

Just published Phase III results in HR+ HER2- mBC care. We would like to thank all patients and investigators in contributing to this research project. https://lnkd.in/dVrCMpmb #clinicaltrials #oncology #breastcancer